Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult participants of all genders (≥18 years old)
Diagnosis of CKD associated with T2D based on assessment by physician.
Treatment according to local marketing authorization, finerenone 20 or 10 mg.Treatment should have been started up to 8 weeks before or after the ICF is signed.
Decision to initiate treatment with finerenone must be made before ICF is signed.
Signed informed consent
You may not be if
Participation in an investigational trial at any time during the course of this study
Contra-indications according to the local label.
Clareo Health | A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting
